scispace - formally typeset
T

Takashi Ikejima

Researcher at Shenyang Pharmaceutical University

Publications -  259
Citations -  9730

Takashi Ikejima is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Apoptosis & Silibinin. The author has an hindex of 47, co-authored 248 publications receiving 8850 citations. Previous affiliations of Takashi Ikejima include Tufts Medical Center & Tufts University.

Papers
More filters
Journal ArticleDOI

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

TL;DR: IL-1, like TNF, possesses the ability to induce hemodynamic and hematological changes typical of septic shock, and that the combination of IL-1 and TNF is more potent than either agent alone.
Journal Article

Interleukin 1 induces interleukin 1. I: Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro

TL;DR: The ability of IL-1 to participate in an amplification event by inducing its own gene expression leading to synthesis of biologically active and immunoreactiveIL-1-beta in human MNC in vitro is examined.
Journal ArticleDOI

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro

TL;DR: The concentrations of tumor necrosis factor (TNF) produced by human peripheral blood mononuclear cells (MNC) were measured using a radioimmunoassay (RIA) for human TNF using a rabbit antiserum against human recombinant TNF, and Hu rTNF labeled with Na1251 by a modification of the chloramine T method.
Journal ArticleDOI

Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.

TL;DR: It is concluded that in TSS the sudden fever and probably other components of the acute phase response may be attributed to a massive release of IL-1.